Back to Screener

Healthcare

Sproutly Canada Inc.(SRUTF)

Live Price

Offline

$0.00001

+0.00% today

1Y Change

+0.00%

Window

Jun 23, 2025 โ†’ Jun 17, 2026

Market Cap
โ€”
Revenue Growth
-65.9%
EPS Growth
+79.8%
Dividend Yield
0.0%

Coverage: 248 bars ยท Jun 23, 2025 โ†’ Jun 17, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Sproutly Canada Inc. (SRUTF) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 0.0% across the available one-year price window (Jun 23, 2025 โ†’ Jun 17, 2026). Baseline metrics include revenue growth of -65.9%, EPS growth of +79.8%, a dividend yield of 0.0%. What stands out right now is revenue -65.9%, EPS +79.8%, free cash flow +83.9% with operating margin -4460.8% and ROIC -920.1%. Valuation is more restrained than many high-expectation growth names at price/sales 0.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines SRUTF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

SRUTF

โ€”

Normalized return

SPY

โ€”

S&P 500

Excess Return

โ€”

Relative to SPY

SRUTF Max Drawdown

0.00%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for SRUTF and SPY.

Calendar-year return history is still loading or unavailable.

Financial profile

Sproutly Canada Inc. (SRUTF)

Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.

FY Revenue

$0.0

FY Net Income

-$186.9K

+47.5% YoY

Free Cash Flow

-$449.5K

-255.2% YoY

Revenue Growth

-65.9%

EPS Growth

+79.8%

Gross Margin

-99.6%

Net Margin

-5186.7%

Income statement

CAD

Annual
Metric20212020201920182017
Revenue316K927K000
Gross Profit-315K-345K134K00
Operating Income-14M-59M-8M-1M-187K
EBITDA-14M-59M-8M27K-187K
Net Income-16M-62M-13M-356K-187K
EPS (Diluted)โ€”โ€”โ€”โ€”โ€”

Balance sheet

CAD

Point-in-time
Metric20212020201920182017
Cash & Equivalents172K32K10M576K26
Total Assets4M17M76M589K213K
Total Liabilities10M13M20M111K67K
Shareholder Equity-6M4M56M478K146K
Total Debt7M11M12M11M0
Net Debt7M11M3M-576K-26

Cash flow positioning

Latest Full Year

Operating Cash Flow

376K

-197.5% YoY

Capital Expenditures

73K

Free Cash Flow

449K

-255.2% YoY

Key ratios

  • Gross Margin

    -99.6%

  • Operating Margin

    -4460.8%

  • Net Margin

    -5186.7%

  • ROE

    1874.9%

  • Debt / Equity

    -1.27x

Next Step

Turn financials into a decision

Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.